Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

Itron's Q1 2026 Revenue Drops 3%

Itron reported first-quarter 2026 revenue of $587 million, down 3% from $607 million a year earlier, as lower legacy electricity product sales in EMEA and softer North American project deployments offset gains elsewhere.

Net income attributable to Itron fell to $53 million from $65 million, while diluted earnings per share declined to $1.18 from $1.42. Adjusted EBITDA rose 5% to $92 million, and free cash flow increased to $79 million from $67 million.

Gross margin improved sharply, with adjusted gross margin rising to 40.7% from the prior-year period, a gain of 490 basis points. Itron said the improvement reflected customer and product mix along with operational efficiencies.

Operating expenses increased. GAAP operating expenses rose to $169 million from $141 million, while non-GAAP operating expenses increased to $154 million from $137 million. GAAP operating income slipped to $68 million from $77 million, but non-GAAP operating income edged up to $84 million from $80 million.

By segment, device solutions revenue fell 1%, or 9% in constant currency. Networked solutions revenue dropped 13%, or 14% in constant currency. Outcomes revenue climbed 22%, or 20% in constant currency, and resiliency solutions contributed $16 million, including revenue from Urbint and LocusView.

Cash from operations improved to $86 million from $72 million. Backlog at quarter end was $4.4 billion, down from $4.7 billion a year earlier, while bookings totaled $476 million.

For the second quarter, Itron guided to revenue of $560 million to $570 million and non-GAAP diluted EPS of $1.25 to $1.35. Following these announcements, the company's shares moved -0.01%, and are now trading at a price of $88.55. Check out the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS